{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:17:49Z","timestamp":1784099869295,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Korean Society of Urology Oncology","award":["KUOS 2014-05"],"award-info":[{"award-number":["KUOS 2014-05"]}]},{"name":"Inje University (KR) research Foundation","award":["20100557"],"award-info":[{"award-number":["20100557"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13000-017-0639-y","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T12:57:24Z","timestamp":1500901044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea"],"prefix":"10.1186","volume":"12","author":[{"given":"Ji Eun","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Hoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Dug","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Mee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghui","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Sun","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Yong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Y.","family":"Ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"639_CR1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466\u201377. discussion 475-7","journal-title":"Eur Urol"},{"key":"639_CR2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71:447\u201361.","journal-title":"Eur Urol"},{"key":"639_CR3","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.humpath.2012.01.008","volume":"43","author":"L Cheng","year":"2012","unstructured":"Cheng L, MacLennan GT, Lopez-Beltran A. Histologic grading of urothelial carcinoma: a reappraisal. Hum Pathol. 2012;43:2097\u2013108.","journal-title":"Hum Pathol"},{"key":"639_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/9781118275436.ch9","volume-title":"Grading of bladder cancer. Bladder pathology","author":"L Cheng","year":"2012","unstructured":"Cheng L, Lopez-Beltran A, Bostwick DG. Grading of bladder cancer. Bladder pathology. Hoboken: Willey-Blackwell; 2012. p. 161\u201387."},{"key":"639_CR5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.eururo.2006.10.037","volume":"51","author":"GT MacLennan","year":"2007","unstructured":"MacLennan GT, Kirkali Z, Cheng L. Histologic grading of noninvasive papillary urothelial Neoplasms. Eur Urol. 2007;51:889\u201398.","journal-title":"Eur Urol"},{"key":"639_CR6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00428-008-0585-x","volume":"452","author":"JW Shim","year":"2008","unstructured":"Shim JW, Cho KS, Choi YD, Park YW, Lee DW, Han WS, et al. Diagnostic algorithm for papillary urothelial tumors in the urinary bladder. Virchows Arch. 2008;452:353\u201362.","journal-title":"Virchows Arch"},{"key":"639_CR7","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1200\/JCO.2003.05.073","volume":"21","author":"BWG Rhijn Van","year":"2003","unstructured":"Van Rhijn BWG, Vis AN, Van der Kwast TH, Kirkel WJ, Radvanyi F, Ooms EC, et al. Molecular grading of Urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol. 2003;21:1912\u201321.","journal-title":"J Clin Oncol"},{"key":"639_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2009.09.013","volume":"57","author":"M Birkhahn","year":"2010","unstructured":"Birkhahn M, Mitra AP, Williams AJ, Lam G, Ye W, Datar RH, et al. Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur Urol. 2010;57:12\u201320.","journal-title":"Eur Urol"},{"key":"639_CR9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/PAS.0000000000000114","volume":"37","author":"M Aron","year":"2013","unstructured":"Aron M, Luthringer DJ, McKenney JK, Hansel DE, Westfall DE, Parakh R, et al. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20\/CD44s\/p53) and \u03b1-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia. Am J Surg Pathol. 2013;37:1815\u201323.","journal-title":"Am J Surg Pathol"},{"key":"639_CR10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/PAI.0b013e31825f3264","volume":"21","author":"MR Raspollini","year":"2013","unstructured":"Raspollini MR, Minervini A, Lapini A, Lanzi F, Rotellini M, Baroni G, et al. A proposed score for assessing progression in pT1 high-grade Urothelial carcinoma of the bladder. Appl Immunohistochem Mol Morphol. 2013;21:218\u201327.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"639_CR11","first-page":"431","volume":"114","author":"J Rajcani","year":"2013","unstructured":"Rajcani J, Kajo K, Adamkov M, Moravekova E, Lauko L, Felcanova D, et al. Immunohistochemical characterization of urothelial carcinoma. Brastisl Lek Listy. 2013;114:431\u20138.","journal-title":"Brastisl Lek Listy"},{"key":"639_CR12","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","volume":"38","author":"MB Amin","year":"2014","unstructured":"Amin MB, Trpkov K, Lopez-Beltran A, Grignon D. Members of the ISUP Immunohistochemistry in diagnostic Urologic pathology group. Best practices recommendations in the application of immunohistochemistry in the bladder lesions. Report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38:e20\u201334.","journal-title":"Am J Surg Pathol"},{"key":"639_CR13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00428-011-1072-3","volume":"458","author":"B Tuna","year":"2011","unstructured":"Tuna B, Y\u00f6r\u00fckoglu K, Duzcan E, Sen S, Nese N, Sars\u0131k B, et al. Histologic grading of urothelial; papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility. Virchows Arch. 2011;458:659\u201364.","journal-title":"Virchows Arch"},{"key":"639_CR14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000100839","volume":"78","author":"II Gonul","year":"2007","unstructured":"Gonul II, Poyraz A, Unsal C, Acar C, Alkibay T. Comparison of 1998 WHO\/ISUP and 1973 WHO classifications for interobserver reliability in grading of papillary urothelial neoplasm of the bladder. Pathological evaluation of 258 cases. Urol Int. 2007;78:338\u201344.","journal-title":"Urol Int"},{"key":"639_CR15","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.ju.0000055471.78783.ae","volume":"169","author":"MG Bol","year":"2003","unstructured":"Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol. 2003;169:1291\u20134.","journal-title":"J Urol"},{"key":"639_CR16","first-page":"99","volume-title":"WHO classification of tumors of the urinary system and male genital organs","author":"VE Reuter","year":"2016","unstructured":"Reuter VE, Comperat E, Algava F, et al. Non-invasive urothelial lesions. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO classification of tumors of the urinary system and male genital organs. 4th ed. Lyon: IARC; 2016. p. 99\u2013107.","edition":"4th"},{"key":"639_CR17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jcp.54.11.854","volume":"54","author":"MG Bol","year":"2001","unstructured":"Bol MG, Baek JP, de Bruin PC, Rep S, Marx W, Bos S, et al. Improved objectivity of grading of TA,1 transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related factors. J Clin Pathol. 2001;54:854\u20139.","journal-title":"J Clin Pathol"},{"key":"639_CR18","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/1097-0142(20000601)88:11<2598::AID-CNCR24>3.0.CO;2-N","volume":"88","author":"JW Oosterhuis","year":"2000","unstructured":"Oosterhuis JW, Schapers RF, Janssen-Heijien ML, Smeets AW, Pauwels RP. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Clinical significance and comparison with other prognostic factors. Cancer. 2000;88:2598\u2013605.","journal-title":"Cancer"},{"key":"639_CR19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","volume":"28","author":"A Malpica","year":"2004","unstructured":"Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28:496\u2013504.","journal-title":"Am J Surg Pathol"},{"key":"639_CR20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0046-8177(95)90010-1","volume":"26","author":"P Robbins","year":"1995","unstructured":"Robbins P, Pinder S, de Klerk N, Dawkins H, Harvey J, Sterrett G, et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol. 1995;26:873\u20139.","journal-title":"Hum Pathol"},{"key":"639_CR21","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.humpath.2014.03.001","volume":"45","author":"OM Mangurud","year":"2014","unstructured":"Mangurud OM, Gudlaugsson E, Skaland I, Tasdemir I, Dalen I, van Diermen B, et al. Prognostic comparison of proliferation makers and World Health Organization 1973\/2004 grade in urothelial carcinoma of the urinary bladder. Hum Pathol. 2014;45:1496\u2013503.","journal-title":"Hum Pathol"},{"key":"639_CR22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.urology.2012.04.010","volume":"80","author":"KE Watts","year":"2012","unstructured":"Watts KE, Montironi R, Mazzucchelli R, van der Kwast T, Osunkoya AO, Stephenson AJ, et al. Clinicopathologic characteristics of 23 cases of invasive low grade papillary urothelial carcinoma. Urologia. 2012;80:361\u20136.","journal-title":"Urologia"},{"key":"639_CR23","first-page":"1238","volume":"11","author":"S Goyal","year":"2014","unstructured":"Goyal S, Singl UR, Sharma S, Kaur N. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer. Urol J. 2014;11:1238\u201347.","journal-title":"Urol J"},{"key":"639_CR24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/cncr.10733","volume":"95","author":"A Pich","year":"2002","unstructured":"Pich A, Chiusa L, Formiconi A, Galliano D, Bortolin P, Comino A, et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer. 2002;95:784\u201390.","journal-title":"Cancer"},{"key":"639_CR25","first-page":"23","volume":"38","author":"AK Akkalp","year":"2016","unstructured":"Akkalp AK, OPnur O, Tetikkurt US, Tolga D, \u00d6zsoy S, M\u00fcsl\u00fcmano\u011flu AY. Prognostic significance of mitotic activity in noninvasive, low grade, papillary urothelial carcinoma. Anal Quant Cytopathol Histopathol. 2016;38:23\u201330.","journal-title":"Anal Quant Cytopathol Histopathol"},{"key":"639_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000337649","volume":"56","author":"CC Solomides","year":"2012","unstructured":"Solomides CC, Birbe R, Nicolau N, Bagley D, Bibbo M. Does mitosis- specific marker phophohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks? Acta Cytol. 2012;56:285\u20138.","journal-title":"Acta Cytol"},{"key":"639_CR27","first-page":"1","volume":"154","author":"WG Rhijn Van","year":"2014","unstructured":"Van Rhijn WG, Musquera M, Liu L, Vis AN, Zuiverloon TC, van Leenders GJ, et al. Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications. Mod Pathol. 2014;154:1\u201311.","journal-title":"Mod Pathol"},{"key":"639_CR28","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/annonc\/mdg377","volume":"14","author":"L Santos","year":"2003","unstructured":"Santos L, Costa C, Pereira S, Koch M, Amaro T, Cardoso F, et al. Neovascularization is a prognostic factor of early recurrence in T1\/G2 urothelial bladder tumors. Ann Oncol. 2003;14:1419\u201324.","journal-title":"Ann Oncol"},{"key":"639_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4132\/KoreanJPathol.2012.46.3.261","volume":"46","author":"TJ Jang","year":"2012","unstructured":"Jang TJ, Kim SW, Lee KS. The expression of pigment epithelium-derived factor in bladder transitional cell carcinoma. Korean J Pathol. 2012;46:261\u20135.","journal-title":"Korean J Pathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-017-0639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T11:50:28Z","timestamp":1659268228000},"score":1,"resource":{"primary":{"URL":"http:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-017-0639-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["639"],"URL":"https:\/\/doi.org\/10.1186\/s13000-017-0639-y","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"article-number":"54"}}